Cited by 142Cholinesterase and Neurodegenerative DiseasesSeaweed-derived Bioactive CompoundsAlzheimer's disease research and treatments

Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro

Open access
Lin, Jiajia, Huang, Ling, Yu, Jie, Xiang, Siying, Wang, Jialing, Zhang, Jinrong, Yan, Xiaojun, Cui, Wei +2 more·2016·Marine Drugs

Abstract

Fucoxanthin, a natural carotenoid abundant in edible brown seaweeds, has been shown to possess anti-cancer, anti-oxidant, anti-obesity and anti-diabetic effects. In this study, we report for the first time that fucoxanthin effectively protects against scopolamine-induced cognitive impairments in mice. In addition, fucoxanthin significantly reversed the scopolamine-induced increase of acetylcholinesterase (AChE) activity and decreased both choline acetyltransferase activity and brain-derived neurotrophic factor (BDNF) expression. Using an in vitro AChE activity assay, we discovered that fucoxanthin directly inhibits AChE with an IC50 value of 81.2 μM. Molecular docking analysis suggests that fucoxanthin likely interacts with the peripheral anionic site within AChE, which is in accordance with enzymatic activity results showing that fucoxanthin inhibits AChE in a non-competitive manner. Based on our current findings, we anticipate that fucoxanthin might exhibit great therapeutic efficacy for the treatment of Alzheimer’s disease by acting on multiple targets, including inhibiting AChE and increasing BDNF expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md14040067

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 142

Authors
Lin, J., Huang, L., Yu, J., Xiang, S., Wang, J., Zhang, J., Yan, X., Cui, W., He, S., & Wang, Q.
Affiliations
Ningbo University (CN)
Corresponding author
  • Cui, Wei
  • He, Shan
  • Wang, Qinwen
Venue
Marine Drugs
Publisher
MDPI AG
Published
2016-03-25
Volume
14
Issue
4
Pages
67
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2304564051
Cited by
142
References
39
Citations by year
2026: 9 · 2025: 10 · 2024: 17 · 2023: 16 · 2022: 24 · 2021: 18 · 2020: 18 · 2019: 3 · 2018: 13 · 2017: 13 · 2016: 1
FWCI
8.09
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81202150, 81471398, 41306134, 41406163)
  • Natural Science Foundation of Zhejiang Province (LY15H310007, LY15090010, LQ13B020004)
  • 863 Program of China (2013AA092902)
  • Ningbo Marine Algae Biotechnology Team (2011B81007)
  • the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry
  • the K. C. Wong Magna Fund in Ningbo University
Topics
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
fucoxanthin, marine carotenoids, scopolamine-induced cognitive impairment, acetylcholinesterase inhibition, choline acetyltransferase, brain-derived neurotrophic factor, Alzheimer's disease, peripheral anionic site, non-competitive inhibition, molecular docking, neuroprotection
MeSH terms
Acetylcholinesterase, Alzheimer Disease, Animals, Carotenoids, Cholinesterase Inhibitors, Male, Mice, Inbred ICR, Scopolamine, Seaweed, Brain-Derived Neurotrophic Factor, Xanthophylls, Mice, Cognitive Dysfunction, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review